BSTC News 23.90 Biospecifics Technologies Corp (BSTC)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biospecifics Technologies Corp (BSTC) 23.90 $BSTC

BioSpecifics Technologies Corp. to Present at the 13th Annual Needham Healthcare Conference
PR Newswire - Wed Apr 02, 7:00AM CDT
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the 13th Annual Needham Healthcare Conference.

OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 7:51AM CST
OncoGenex Pharmaceuticals, Inc. was a big mover last session, as its shares rose nearly 7% on the day.

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2013 Financial Results
PR Newswire - Thu Mar 06, 7:00AM CST
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2013 and provided a corporate update.

Auxilium Pharma Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 10:00AM CST
Revenues were boosted by the recently acquired subsidiary, Actient, as well as higher Xiaflex sales in the U.S.

Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (strong buy) List for Monday

Alcobra (ADHD) Jumps: Stock Rises 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 8:04AM CST
Alcobra Ltd. was a big mover last session, as the company saw its shares rise by over 8% on the day.

Durata Therapeutics (DRTX) Jumps: Stock Rises 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:21AM CST
Durata Therapeutics, Inc. (DRTX) was a big mover last session, as the company saw its shares rise by over 6% on the day.

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (strong buy) List for Friday

Positive Data on BioSpecifics/ Auxilium's Xiaflex - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 09, 11:10AM CST
BioSpecifics Technologies recently announced encouraging top-line data on Xiaflex from a phase II dose escalation clinical trial for the treatment of human lipoma.

Biotech Stock Roundup: Christmas Gift for UTHR, TSRO Tumbles - Analyst Blog
Arpita Dutt - Zacks Investment Research - Thu Jan 02, 9:48AM CST
Altogether it was a slow week for the biotech sector though companies like UTHR made the headlines.

Update on BioSpecifics/ Auxilium's Xiaflex - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 27, 3:20PM CST
BioSpecifics Technologies is working hard to develop its pipeline .

Pipeline Progress at Auxilium Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 16, 2:35PM CST
Auxilium Pharmaceuticals recently dosed its first patient for the phase II study on Xiaflex for the treatment of frozen shoulder syndrome (adhesive capsulitis).

Auxilium Up on Peyronie's Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 9:40AM CST
Xiaflex, currently marketed for Dupuytren's Contracture, gained FDA approval for Peyronie's disease.

Zacks #1 Rank Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 7:30AM CST
Here are 5 stocks added to the Zacks #1 Rank ("strong buy" List for Monday

BioSpecifics Technologies Corp. (BSTC) in Focus: Stock Moves 6.5% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 7:21AM CST
BioSpecifics Technologies Corp. (BSTC) was a big mover last session, as the company saw its shares rise by roughly 7% on the day.

FDA approves first drug for rare erection disorder
AP - Fri Dec 06, 1:34PM CST
WASHINGTON (AP) — The Food and Drug Administration on Friday approved the first drug to treat an unusual condition that causes painful, curved erections in men.

Cadence Pharmaceuticals Inc. (CADX) Jumps: Stock Rises 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 04, 7:32AM CST
Cadence Pharmaceuticals Inc. was a big mover last session, as the company saw its shares rise over 6% on the day.

Zacks #1 Rank Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 03, 7:30AM CST
Here are 5 stocks added to the Zacks #1 Rank ("strong buy" List for Tuesday

Data on Auxilium Pharma's Xiaflex - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 10:10AM CST
Auxilium Pharma announced encouraging results on Xiaflex from the MULTICORD (Multiple Treatment Investigation of Collagenase Optimizing the Resolution of Dupuytren's) study.

Regulatory Setback for Forest/Gedeon - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 9:30AM CST
Forest Labs and Gedeon Richter intend to meet with the FDA shortly to determine the path forward for cariprazine.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Independents Finally Center Stage on Election Night

Updated Category News Views 36

Unprecedented Spotlight on Independent Voters The political landscape is in for a shake-up, folks. Come November 3rd, we're witnessing something that hasn't been done before—an entire Election Night dedicated exclusively to independent voters. It’s high time these folks got the spotlight, considering a whopping 45% of U.S. adults have shunned the extremist seesaw of...

Continue Reading
HIMS Lawsuit: Investors Under the Gun Before Deadline

Updated Category News Views 46

HIMS Investors Find Themselves in Hot Water Well, it looks like the ball's in your court, folks. Hims & Hers Health, Inc. (NYSE: HIMS) has been caught in a whirlwind of legal drama, and if you're holding any $HIMS stock, you've got some decisions to make—and fast. With a looming November 2 deadline to step up in a securities class action, this is one of those...

Continue Reading
Artprice Champions Creative Freedom with AI in 2026

Updated Category News Views 96

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Continue Reading
111, Inc. Strategizes with Advisors Amid Proposal Talks

Updated Category News Views 112

Every time a company's board starts tossing around phrases like "strategic alternatives," you’ve got to pay closer attention. 111, Inc., holding the NASDAQ ticker YI, is one such entity at a crossroads. They've enlisted Houlihan Lokey China Limited as their independent financial advisor and Kirkland & Ellis as their U.S. legal counsel to sift through potential strategic...

Continue Reading
American Water's $10K Grant Boosts Student Financial Skills

Updated Category News Views 0

Financial Literacy: Building Skills for the Future When it comes to prepping kids for the real world, it's not just about packing their backpacks with textbooks and pencils; it's about arming them with the know-how to make smart financial moves. American Water Charitable Foundation's recent $10,000 grant to Junior Achievement of the Heartland is a shining example of the...

Continue Reading
Metallium's U.S. Supply Chain Ambitions Hinge on Traxys MOU

Updated Category News Views 111

Metallium and Traxys Partner to Boost U.S. Critical Metals Out there in Houston, October's cooked up a potential game-changer for U.S. critical metals supply like no one's business. Metallium Limited—those savvy cats juggling ASX and OTC markets—just laid down a non-binding Memorandum of Understanding (MOU) with Traxys North America LLC. The goal? To sharpen up and...

Continue Reading
Govee's Retro Holiday Lights: A Festive Nostalgia Trip

Updated Category News Views 64

Ah, the holidays—they're creeping up like a kid sneaking downstairs for a peek at their gifts. But it's not the gifts under the tree that brighten a room, it's those lights draping the tree itself. Enter Govee, bringing us back to that vintage glow we all remember from our childhoods. They've teamed up with Brady Tolbert, a design whiz who can make a living room look...

Continue Reading
Mesirow Expands Retirement Reach with flexPATH Deal

Updated Category News Views 126

Retirement Industry Shake-Up Here's the scoop: Mesirow's swinging big in the retirement scene with its latest acquisition of flexPATH's plan-level 3(38) business. In the world of outsourced fiduciarity—for thems ain't in the know—that's like bolting a turbocharger to an already darn good engine. Mesirow might just be strapping itself in for a wild ride in this 2026...

Continue Reading
Sirha Lyon® 2027: A New Chapter in Foodservice

Updated Category News Views 135

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Continue Reading
Sinopec's Catalyst Conference: Driving Global Innovation

Updated Category News Views 90

The Role of Catalysts in Modern Industry Swing by any bustling industrial hub, and you're likely to catch talk about catalysts—unsung heroes that make the machinery of modern industry run smoother, faster, and cleaner. Over in Tianjin, China, Sinopec just wrapped up its Second International Catalyst Customer Conference, which is less of a tongue-twister than it sounds....

Continue Reading

Top 5 Most Recently Viewed Articles

Rezolve Ai Achieves Major Growth with Russell Index Inclusion

Updated Category News Views 322

Rezolve Ai Celebrates Inclusion in Prestigious Russell Indices Rezolve Ai (NASDAQ: RZLV) has reached a significant milestone in its journey by being added to the Russell 2000 and Russell 3000 indices. This achievement comes as a result of an immensely successful year, with the company's annual recurring revenue (ARR) soaring to $70 million, showcasing its rapid growth...

Continue Reading
VitalHub Demonstrates Growth with Strong 2024 Financials

Updated Category News Views 369

VitalHub Reports Impressive Financial Growth VitalHub Corp, a prominent software provider in health and human services, recently reported robust financial results for 2024. The company disclosed significant advancements in their Annual Recurring Revenue (ARR), which surged 59% year over year, reaching $71.1 million. Additionally, the total revenue increased by a...

Continue Reading
Artius II Acquisition Inc. Launches $200 Million IPO on Nasdaq

Updated Category News Views 229

Artius II Acquisition Inc. Launches Its Initial Public Offering In an exciting development for investors and the market, Artius II Acquisition Inc. has unveiled its initial public offering (IPO) priced at an impressive $200 million. This marks a significant moment for the company as it takes steps to expand its reach in the investment landscape. Understanding the IPO...

Continue Reading
Surge in Foreign Capital Sparks Japanese Stock Market Growth

Updated Category News Views 85

Foreign Investment Surge in Japanese Stocks Recent trends indicate a remarkable increase in foreign investments in Japanese stocks, particularly noted in the week ending October 5. Following comments from Prime Minister Shigeru Ishiba regarding monetary policy, the yen experienced a depreciation, enhancing the appeal of Japanese exporters to foreign buyers. Significant...

Continue Reading
Jason Maynard Takes the Helm as CEO of Qualtrics

Updated Category News Views 194

Qualtrics Welcomes Jason Maynard as New CEO Qualtrics, a pioneer in experience management, has recently appointed Jason Maynard as its Chief Executive Officer. Maynard, who will also take a seat on the Qualtrics Board of Directors, officially steps into this influential role today. A Leader with Proven Experience With an impressive background of 30 years in the technology...

Continue Reading